Previous 10 | Next 10 |
2024-01-04 00:30:00 ET Summary The S&P 500 is still within 2% of its record closing high reached exactly two years ago on January 3rd, but beneath the surface, there have been some big moves. While the S&P 500 is down 1.9% from its high, over that same period, the ‘...
2024-01-03 17:17:52 ET Summary Bristol-Myers Squibb Company experienced a poor year in terms of share price performance in 2023, with a 27% decline in value. Bristol-Myers has focused on its late-stage pipeline and made several recent acquisitions geared towards offsetting losses ...
2024-01-03 12:20:11 ET Shares of Eli Lilly (NYSE: LLY) were jumping 3.3% higher as of 12:07 p.m. ET on Wednesday. This gain looked even better considering that the major market indexes were all slumping. Lilly was able to swim against the market current primarily because of inve...
2024-01-03 11:08:50 ET Pharmaceutical company Eli Lilly & Co (NYSE: LLY) is the world's largest drug company. It minted many millionaires on its way to becoming one of the world's largest corporations. The stock has returned an incredible 41,930% over its lifetime, turning a $1,...
2024-01-03 07:00:00 ET Summary The biotech industry experienced a challenging year in 2023 due to a rising 10-year Treasury yield. In 2024, the 10-year yield should favorably support biotech stocks. Promising advancements in weight loss drugs, neuroscience, oncology, and gene ...
2024-01-02 10:17:03 ET More on Inspire Medical Systems Inspire Medical Systems: Time To Wake Up Inspire Medical Systems, Inc. (INSP) Q3 2023 Earnings Call Transcript Inspire Medical Systems, Inc. 2023 Q3 - Results - Earnings Call Presentation Inspire Medical ...
2024-01-02 06:12:49 ET Summary Spending on anti-obesity medication is increasing, with some individuals spending more on medication than on food. Novo Nordisk's semaglutide drug, sold as Wegovy, is in high demand and the company is struggling to meet the soaring demand. Expend...
2024-01-01 09:37:00 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tu...
2024-01-01 08:30:00 ET Summary I discuss the top five stocks investors should avoid buying at the current levels unless we get a steep pullback. It's important to consider that market outperformance could be challenging as the market rotates to other stocks. While the quality ...
2024-01-01 07:15:00 ET Eli Lilly (NYSE: LLY) has been one of the hottest healthcare stocks to own in recent years. The company is now the most valuable healthcare company in the world, with a valuation of around $550 billion. So, investors may be wondering whether the stock has peak...
News, Short Squeeze, Breakout and More Instantly...
2024-07-30 07:07:00 ET If your portfolio doesn't have exposure to the biopharma businesses pursuing the development of weight loss medicines, it might be time to consider changing that situation. With an influx of new drugs for sale, and many competitors looking to secure their share of the...
2024-07-30 05:48:00 ET Going into 2024, DexCom 's (NASDAQ: DXCM) shares were up a whopping 14 times over the last 10 years. The company's continuous glucose monitoring (CGM) devices enjoyed tremendous demand from individuals with diabetes. However, last week was the worst for De...
2024-07-29 15:13:21 ET Eli Lilly & Co (NYSE: LLY) has recently experienced a dramatic $123 billion decline in market value. This significant drop follows positive developments from competitors, notably Viking Therapeutics Inc and Roche Holding AG, who made announcements regarding th...